Nathalie Reveneau

Title: Nathalie Reveneau: Innovator in Immunogenic Compositions

Introduction

Nathalie Reveneau is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of immunology through her innovative research and development of immunogenic compositions. Her work focuses on enhancing immune responses, which is crucial for advancing medical treatments.

Latest Patents

Nathalie holds a patent for her invention titled "Immunogenic compositions." This patent provides compositions that include a Chlamydial major outer membrane protein (MOMP) from at least one Chlamydial serovar and an adjuvant. The adjuvant comprises the product E6020, which has the CAS Number 287180-63-6. The composition may also include at least one carrier system, such as an emulsion or mineral particle. The MOMP protein can be derived from various species, and the invention outlines methods for inducing an immune response in a subject by administering the composition.

Career Highlights

Throughout her career, Nathalie has worked with notable companies, including Sanofi Pasteur Inc. and Sanofi Pasteur S.A. Her experience in these organizations has allowed her to contribute to significant advancements in vaccine development and immunology.

Collaborations

Nathalie has collaborated with esteemed colleagues, including Scott Gallichan and Ausra Mancevski. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.

Conclusion

Nathalie Reveneau is a trailblazer in the development of immunogenic compositions, with a focus on improving immune responses. Her contributions to the field of immunology are invaluable, and her patent reflects her commitment to advancing medical science.